Activity of RX-04 Pyrrolocytosine Protein Synthesis Inhibitors against Multidrug-Resistant Gram-Negative Bacteria
- PMID: 29914946
- PMCID: PMC6105809
- DOI: 10.1128/AAC.00689-18
Activity of RX-04 Pyrrolocytosine Protein Synthesis Inhibitors against Multidrug-Resistant Gram-Negative Bacteria
Abstract
Pyrrolocytosines RX-04A to -D are designed to bind to the bacterial 50S ribosomal subunit differently from currently used antibiotics. The four analogs had broad anti-Gram-negative activity: RX-04A-the most active analog-inhibited 94.7% of clinical Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa at 0.5 to 4 μg/ml, with no MICs of >8 μg/ml. MICs for multidrug-resistant (MDR) carbapenemase producers were up to 2-fold higher than those for control strains; values were highest for one Serratia isolate with porin and efflux lesions. mcr-1 did not affect MICs.
Keywords: 50S ribosomal subunit; blasticidin; mcr-1; pyrrolocytosine.
© Crown copyright 2018.
References
-
- Duffy E, Devivo M, Kanyo Z, Bhattacharjee. 2011. The molecular tuning of RX-04, a novel broad spectrum antibacterial class for coverage of MDR Gram-negative pathogens, abstr FI-1843. Abstr 51st Intersci Conf Antimicrob Agents Chemother.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
